ZA935120B - Medicinal compositions for the improvement of blood coagulation comprising TCF-II - Google Patents

Medicinal compositions for the improvement of blood coagulation comprising TCF-II

Info

Publication number
ZA935120B
ZA935120B ZA935120A ZA935120A ZA935120B ZA 935120 B ZA935120 B ZA 935120B ZA 935120 A ZA935120 A ZA 935120A ZA 935120 A ZA935120 A ZA 935120A ZA 935120 B ZA935120 B ZA 935120B
Authority
ZA
South Africa
Prior art keywords
tcf
improvement
blood coagulation
medicinal compositions
medicinal
Prior art date
Application number
ZA935120A
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Publication of ZA935120B publication Critical patent/ZA935120B/en

Links

ZA935120A 1992-07-16 1993-07-15 Medicinal compositions for the improvement of blood coagulation comprising TCF-II ZA935120B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21222892 1992-07-16

Publications (1)

Publication Number Publication Date
ZA935120B true ZA935120B (en) 1994-02-08

Family

ID=16619084

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935120A ZA935120B (en) 1992-07-16 1993-07-15 Medicinal compositions for the improvement of blood coagulation comprising TCF-II

Country Status (1)

Country Link
ZA (1) ZA935120B (en)

Similar Documents

Publication Publication Date Title
EP0572828A3 (en) Ophthalmologic cannula
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
HU9300536D0 (en) Compounds of medical effect
AU2806692A (en) Medicament for the treatment of anxiety
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
ZA906355B (en) Pharmaceutical compositions for the treatment of multiple sclerosis
AU6975891A (en) Pharmaceutical compositions for the treatment of drug dependence
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases
AU5435994A (en) The use of inositoltrisphosphate for the preparation of medicaments
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria